Lupin informs about press release

21 Nov 2023 Evaluate

Lupin has informed that it enclosed a Press release regarding receipt of US FDA approval for the Company’s Abbreviated New Drug Application for Pitavastatin Tablets, 1 mg, 2 mg, and 4 mg, to market a generic equivalent of Livalo Tablets, 1 mg, 2 mg, and 4 mg, of Kowa Company. 

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2312.00 13.75 (0.60%)
18-Mar-2026 14:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1783.70
Dr. Reddys Lab 1295.95
Cipla 1273.90
Zydus Lifesciences 901.15
Lupin 2312.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×